Increased Expression of miR-155 in Peripheral Blood and Wound Margin Tissue of Type 2 Diabetes Mellitus Patients Associated with Diabetic Foot Ulcer

References

• Lim JZM, Ng NSL, Thomas C. Prevention and treatment of diabetic foot ulcers. J Roy Soc Med. 2017;110(3):104–109. doi:10.1177/0141076816688346
   PubMed Web of Science ®Google Scholar
• Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. New Engl J Med. 2017;376(24):2367–2375. doi:10.1056/NEJMra1615439
   PubMed Web of Science ®Google Scholar
• Bandyk DF. The diabetic foot: pathophysiology, evaluation, and treatment. Semin Vasc Surg. 2018;31(2–4):43–48. doi:10.1053/j.semvascsurg.2019.02.001
   PubMed Web of Science ®Google Scholar
• Goodarzi G, Maniati M, Qujeq D. The role of microRNAs in the healing of diabetic ulcers. Int Wound J. 2019;16(3):621–633. doi:10.1111/iwj.13070
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465. doi:10.1002/jcp.27486
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan microRNAs. Cell. 2018;173(1):20–51. doi:10.1016/j.cell.2018.03.006
   PubMed Web of Science ®Google Scholar
• Vigorito E, Kohlhaas S, Lu D, Leyland R. miR-155: an ancient regulator of the immune system. Immunol Rev. 2013;253(1):146–157. doi:10.1111/imr.12057
   PubMed Web of Science ®Google Scholar
• Arbore G, Henley T, Biggins L, et al. MicroRNA-155 is essential for the optimal proliferation and survival of plasmablast B cells. Life Sci Alliance. 2019;2(3):e201800244. doi:10.26508/lsa.201800244
   Web of Science ®Google Scholar
• Guo P, Qiao F, Huang D, et al. MiR-155-5p plays as a “janus” in the expression of inflammatory cytokines induced by T-2 toxin. Food Chem Toxicol. 2020;140:111258. doi:10.1016/j.fct.2020.111258
   Web of Science ®Google Scholar
• Yang L, Zheng Z, Zhou Q, et al. miR-155 promotes cutaneous wound healing through enhanced keratinocytes migration by MMP-2. J Mol Histol. 2017;48(2):147–155. doi:10.1007/s10735-017-9713-8
   Web of Science ®Google Scholar
• Hou RX, Liu RF, Zhao XC, et al. Increased miR-155-5p expression in dermal mesenchymal stem cells of psoriatic patients: comparing the microRNA expression profile by microarray. Genet Mol Res. 2016;15(3). doi:10.4238/gmr.15038631.
   Web of Science ®Google Scholar
• Moura J, Sørensen A, Leal EC, et al. microRNA-155 inhibition restores Fibroblast Growth Factor 7 expression in diabetic skin and decreases wound inflammation. Sci Rep. 2019;9(1):5836. doi:10.1038/s41598-019-42309-4
   PubMed Web of Science ®Google Scholar
• Ye J, Kang Y, Sun X, Ni P, Wu M, Lu S. MicroRNA-155 inhibition promoted wound healing in diabetic rats. Int J Low Extrem Wounds. 2017;16(2):74–84. doi:10.1177/1534734617706636
   Web of Science ®Google Scholar
• Wang CR, Zhu HF, Zhu Y. Knockout of microRNA-155 ameliorates the Th17/Th9 immune response and promotes wound healing. Curr Med Sci. 2019;39(6):954–964. doi:10.1007/s11596-019-2128-x
   Web of Science ®Google Scholar
• Gondaliya P, Sayyed AA, Bhat P, et al. Mesenchymal stem cell-derived exosomes loaded with miR-155 inhibitor ameliorate diabetic wound healing. Mol Pharm. 2022;19(5):1294–1308. doi:10.1021/acs.molpharmaceut.1c00669
   PubMed Web of Science ®Google Scholar
• Li X, Tang Y, Jia Z, Zhao X, Chen M. Decreased expression of miR-24 in peripheral plasma of type 2 diabetes mellitus patients associated with diabetic foot ulcer. Wound Repair Regen. 2020;28(6):728–738. doi:10.1111/wrr.12850
   Web of Science ®Google Scholar
• Sharma D, Singh B, Jaswal KS, Thakur V, Nabh R. Effectiveness of negative pressure wound therapy in the management of chronic diabetic ulcers: a prospective study. Int Surg J. 2017;4(4):1313. doi:10.18203/2349-2902.isj20171134
   Google Scholar
• Perkins NJ, Schisterman EF. The inconsistency of “optimal” cut-points obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):6. doi:10.1093/aje/kwj063
   Web of Science ®Google Scholar
• Lin X, Qin Y, Jia J, et al. MiR-155 enhances insulin sensitivity by coordinated regulation of multiple genes in mice. PLoS Genet. 2016;12(10):e1006308. doi:10.1371/journal.pgen.1006308
   PubMed Web of Science ®Google Scholar
• Zhu M, Wei Y, Geißler C, et al. Hyperlipidemia-induced microRNA-155-5p improves β-cell function by targeting Mafb. Diabetes. 2017;66(12):3072–3084. doi:10.2337/db17-0313
   Web of Science ®Google Scholar
• Corral-Fernández NE, Salgado-Bustamante M, Martínez-Leija ME, et al. Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2013;121(6):347–353. doi:10.1055/s-0033-1341516
   PubMed Web of Science ®Google Scholar
• Nunez Lopez YO, Garufi G, Seyhan AA. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Mol Biosyst. 2016;13(1):106–121. doi:10.1039/C6MB00596A
   PubMedGoogle Scholar
• Xiang Y, Cheng J, Wang D, et al. Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor. Blood. 2015;125(22):3377–3387. doi:10.1182/blood-2015-01-620278
   PubMed Web of Science ®Google Scholar
• Liu J, Shi K, Chen M, et al. Elevated miR-155 expression induces immunosuppression via CD39(+) regulatory T-cells in sepsis patient. Int J Infect Dis. 2015;40:135–141. doi:10.1016/j.ijid.2015.09.016
   Web of Science ®Google Scholar
• Chen CG, Luo BS, Wang C. Potential role of miR-425, miR-155 and miR-33 in Streptococcus pneumoniae pneumonia by using bioinformatics analysis and experimental validation. J Biol Regul Homeost Agents. 2021;35(3):953–964. doi:10.23812/21-120-A
   Web of Science ®Google Scholar
• Chinese Diabetes Society, Chinese Society of Infectious Diseases, Chinese Society for Tissue Repair and Regeneration. Chinese guideline on prevention and management of diabetic foot. Chin J Diabetes Mellitus. 2019;11(2):92–108.
   Google Scholar
• Tindong M, Palle JN, Nebongo D, et al. Prevalence, clinical presentation, and factors associated with diabetic foot ulcer in two regional hospitals in Cameroon. Int J Low Extrem Wounds. 2018;17(1):42–47. doi:10.1177/1534734618764252
   Web of Science ®Google Scholar
• van Netten JJ, Price PE, Lavery LA, et al.; International Working Group on the Diabetic Foot. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32(Suppl 1):84–98. doi:10.1002/dmrr.2701
   PubMed Web of Science ®Google Scholar
• Nickinson ATO, Bridgwood B, Houghton JSM, et al. A systematic review investigating the identification, causes, and outcomes of delays in the management of chronic limb-threatening ischemia and diabetic foot ulceration. J Vasc Surg. 2020;71(2):669–681.e2. doi:10.1016/j.jvs.2019.08.229
   Web of Science ®Google Scholar
• van Solingen C, Araldi E, Chamorro-Jorganes A, Fernández-Hernando C, Suárez Y. Improved repair of dermal wounds in mice lacking microRNA-155. J Cell Mol Med. 2014;18(6):1104–1112. doi:10.1111/jcmm.12255
   Web of Science ®Google Scholar
• Catrina SB, Zheng X. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers. Diabetes Metab Res Rev. 2016;32(Suppl 1):179–185. doi:10.1002/dmrr.2742
   Web of Science ®Google Scholar
• Liu S, Chen J, Shi J, et al. M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment. Basic Res Cardiol. 2020;115(2):22. doi:10.1007/s00395-020-0781-7
   PubMed Web of Science ®Google Scholar
• Gao J, Zhao G, Li W, et al. MiR-155 targets PTCH1 to mediate endothelial progenitor cell dysfunction caused by high glucose. Exp Cell Res. 2018;366(1):55–62. doi:10.1016/j.yexcr.2018.03.012
   Web of Science ®Google Scholar
• Niu LJ, Zhang YM, Huang T, Sun XF, Luo SX. Exosomal microRNA-155 as a biomarker for hepatic fibrosis diagnosis and progression. Ann Transl Med. 2021;9(2):137. doi:10.21037/atm-20-7787
   Web of Science ®Google Scholar
• Shao C, Yang F, Qin Z, Jing X, Shu Y, Shen H. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis. BMC Cancer. 2019;19(1):1103. doi:10.1186/s12885-019-6297-6
   Web of Science ®Google Scholar
• Liu L, Chen R, Jia Z, et al. Downregulation of hsa-miR-203 in peripheral blood and wound margin tissue by negative pressure wound therapy contributes to wound healing of diabetic foot ulcers. Microvasc Res. 2022;139:104275. doi:10.1016/j.mvr.2021.104275
   PubMed Web of Science ®Google Scholar